Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
With the slowdown in world economic growth, the 3D Cell Culture Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, 3D Cell Culture market size to maintain the average annual growth rate of 0.0662859590263 from 370.0 million $ in 2014 to 510.0 million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, 3D Cell Culture market size will be further expanded, we expect that by 2023, The market size of the 3D Cell Culture will reach 950.0 million $.
3D cell culture is an artificial environment in which biological cells are allowed to grow in all three dimensions. This advanced technique promotes the proliferation and migration of normal cells by interacting with their three-dimensional surroundings. In a 3D environment, cells are more subjected to physiological and morphological changes compared to those grown in 2D surroundings. Moreover, 3D models are more accurate models mimicking in vivo cell behavior in terms of histologic, physiologic, and functional properties. Cancer research, stem cell research, drug discovery, and regenerative medicine are some of the major application areas of 3D cell culture.
The rising application of 3D cell culture in drug discovery and regenerative medicine field for exploring more aspects of the disease is estimated to foster the market growth of 3D cell culture. Growing cases of cancer is another major factor anticipated to augment the market growth of 3D cell culture. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.
From the geographical perspective, North America is expected to exhibit significant growth over the forecast timeframe due to the introduction of the advent of advancement in 3D cell culture. For instance, in February 2017, Greiner Bio-One North America, Inc. has added the innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™ offers a versatile system for the propagation of adherent mammalian cells from research scale to industrial batches.
On the other hand, the high cost associated with the implementation of 3D cell culture is expected to hinder the market growth over the forecast timeframe.
Key Developments:
- In October 2019, Corning Incorporated announced two additions to its 3D cell culture portfolio that offer new solutions to support spheroid and organoid culture models. Elplasia®, a 3D cell culture microplate, features a microcavity technology that enables high volume spheroid formation, culture, and analysis.
- In April 2016, TheWell Bioscience announces the launch of new product launch: VitroGel 3D, a ready-to-use hydrogel for 3D cell culture
- In September 2019, Jellagen has developed a unique manufacturing process, Jellatech™ that allows laboratory technicians to scale up the production of the material and also capitalize on the simple physiology of jellyfish to support batch-to-batch consistency. JellaGel™ is a jellyfish collagen hydrogel, suitable for 3D cell culture and tissue engineering.
This Report covers the manufacturers' data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume, and value, as well as price data.
Besides, the report also covers segment data, including type segment, industry segment, channel segment, etc. cover different segment market sizes, both volume, and value. Also cover different industries client's information, which is very important for the manufacturers. If you need more information,
Section 1: Definition
Section (2 3): Manufacturer Detail
╼ Thermo Fisher Scientific
╼ Corning
╼ Lonza Group
╼ Kuraray Co
╼ Merck Kgaa
╼ Insphero
╼ N3d Bioscience
╼ Reprocell Incorporated
╼ 3D Biotek
Section 4: Region Segmentation
╼ North America Country (United States, Canada)
╼ South America
╼ Asia Country (China, Japan, India, Korea)
╼ Europe Country (Germany, UK, France, Italy)
╼ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Type Segmentation
Product Type Segmentation ⤍
╼ Scaffold-based
╼ Scaffold-free
Industry Segmentation ⤍
╼ Cancer Research
╼ Stem Cell Research
╼ Drug Discovery
╼ Regererative Medicine
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
